CEACAM5 and lung cancer: The conflicting results may indicate that serum CEA alone is not sufficiently sensitive for monitoring patient outcomes; however, the combination of CT findings and pre/postoperative serum CEA levels provides reliable prognostic information for DFS and OS in lung cancer patients (Takamochi et al., 2004; Higashi et al., 2009; Yamazaki et al., 2015).